Coding Ahead
CasePilot
Medical Coding Assistant
Case2Code
Search and Code Lookup Tool
RedactPHI
HIPAA-Compliant PHI Redaction
DetectICD10CM
ICD-10-CM Code Detection
Log in Register free account
1 code page views remaining. Guest accounts are limited to 1 page view. Register free account to get 5 more views.
Log in Register free account

Official Description

Initial placement of a drug-eluting ocular insert under one or more eyelids, including fitting, training, and insertion, unilateral or bilateral

© Copyright 2025 American Medical Association. All rights reserved.

Common Language Description

The procedure described by CPT® Code 0444T involves the initial placement of a drug-eluting ocular insert beneath one or more eyelids. This insert is a specialized medical device designed to deliver medication directly to the eye over an extended period. The ocular insert is composed of a thin, sterile, multi-layered structure, featuring an inner polymeric support that provides stability and an outer layer that is impregnated with a specific drug or medication. When placed under the eyelid, the insert rests on the conjunctiva, which is the membrane covering the white part of the eye and the inner eyelids. The unique design of the insert allows lacrimal fluid, which is the natural fluid produced by the tear glands, to permeate the outer membrane of the device. This process facilitates the controlled diffusion of the medication into the ocular surface, ensuring a steady release of the drug over time. To perform the insertion, the healthcare provider first measures the intercanthal distance, which is the distance between the inner corners of the eyes, to select the appropriate size of the ocular insert. Prior to the procedure, a topical ophthalmic anesthetic may be applied to minimize discomfort for the patient. The upper eyelid is then manually retracted to allow access to the upper fornix, where the insert is placed. Following this, the lower eyelid is also retracted, either manually or with the assistance of a scleral depressor, to position the lower half of the insert in the lower fornix. It is important that a portion of the insert remains visible in the medial canthus, which is the inner corner of the eye. After the placement, the patient receives instructions on how to care for the insert and manage it if it becomes slightly displaced. For removal, the lower lid is retracted to expose the insert, and the exposed ring of the insert is gripped and pulled out of the eye. This comprehensive procedure encapsulates the initial fitting, training, and placement of the drug-eluting ocular insert, whether performed unilaterally or bilaterally.

© Copyright 2025 Coding Ahead. All rights reserved.

1. Indications

The procedure described by CPT® Code 0444T is indicated for patients requiring sustained medication delivery to the ocular surface. The specific indications for this procedure include:

  • Chronic Eye Conditions Patients suffering from chronic conditions such as glaucoma or dry eye syndrome may benefit from the continuous release of medication provided by the ocular insert.
  • Post-Surgical Care Individuals who have undergone ocular surgery may require ongoing medication to aid in recovery and prevent complications.
  • Medication Adherence Issues Patients who have difficulty adhering to a prescribed medication regimen may find the ocular insert a more effective solution for consistent medication delivery.

2. Procedure

The procedure for the initial placement of a drug-eluting ocular insert involves several detailed steps to ensure proper fitting and insertion. The steps are as follows:

  • Step 1: Measurement of Intercanthal Distance The healthcare provider begins by measuring the intercanthal distance, which is the distance between the inner corners of the eyes. This measurement is crucial for selecting the appropriate size of the ocular insert to ensure a proper fit.
  • Step 2: Application of Anesthetic A topical ophthalmic anesthetic may be instilled in the eye to minimize discomfort during the procedure. This step is essential for patient comfort and cooperation during the insertion process.
  • Step 3: Retraction of the Upper Eyelid The upper eyelid is manually retracted to provide access to the upper fornix, which is the space between the eyelid and the eyeball. This allows the healthcare provider to place the insert accurately.
  • Step 4: Insertion of the Upper Half of the Insert The drug-eluting ocular insert is then placed in the upper fornix, ensuring that it is positioned correctly for optimal drug delivery.
  • Step 5: Retraction of the Lower Eyelid The lower eyelid is retracted either manually or with the aid of a scleral depressor to facilitate the placement of the lower half of the insert.
  • Step 6: Insertion of the Lower Half of the Insert The lower half of the insert is positioned in the lower fornix, ensuring that a portion of the insert remains visible in the medial canthus, which is the inner corner of the eye.
  • Step 7: Patient Instruction After the insertion, the patient is instructed on the proper care of the ocular insert, including how to manage it if it becomes slightly displaced. This education is vital for ensuring the effectiveness of the treatment.

3. Post-Procedure

Post-procedure care following the placement of a drug-eluting ocular insert involves monitoring for any immediate complications and ensuring the patient understands how to care for the insert. Patients are typically advised to avoid rubbing their eyes and to report any discomfort, excessive tearing, or signs of infection. Follow-up appointments may be scheduled to assess the position of the insert and the effectiveness of the medication delivery. If the insert needs to be removed, the procedure for removal is similar to the insertion process, where the lower lid is retracted to expose the insert, and the exposed ring is gripped and pulled from the eye. Proper follow-up care is essential to ensure the ongoing effectiveness of the treatment and to address any potential issues that may arise.

Short Descr 1ST PLMT DRUG ELUT OC INS
Medium Descr INITIAL PLMT DRUG ELUTING OCULAR INSERT UNI/BI
Long Descr Initial placement of a drug-eluting ocular insert under one or more eyelids, including fitting, training, and insertion, unilateral or bilateral
Status Code Carriers Price the Code
Global Days YYY - Carrier Determines Whether Global Concept Applies
PC/TC Indicator (26, TC) 0 - Physician Service Code
Multiple Procedures (51) 0 - No payment adjustment rules for multiple procedures apply.
Bilateral Surgery (50) 0 - 150% payment adjustment for bilateral procedures does NOT apply.
Physician Supervisions 09 - Concept does not apply.
Assistant Surgeon (80, 82) 0 - Payment restriction for assistants at surgery applies to this procedure...
Co-Surgeons (62) 0 - Co-surgeons not permitted for this procedure.
Team Surgery (66) 0 - Team surgeons not permitted for this procedure.
Diagnostic Imaging Family 99 - Concept Does Not Apply
APC Status Indicator Items and Services Packaged into APC Rates
ASC Payment Indicator Packaged service/item; no separate payment made.
Berenson-Eggers TOS (BETOS) P5E - Ambulatory procedures - other
MUE 1
Date
Action
Notes
2017-01-01 Added First appearance in codebook.
2016-07-01 Added Code Added.
Code
Description
CasePilot

Get instant expert-level medical coding assistance.

Ask about:
CPT Codes Guidelines Modifiers Crosswalks NCCI Edits Compliance Medicare Coverage
Example: "What is CPT code 99213?" or "Guidelines for E/M services"